Search

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

Z
Zà T. - A SURVEY ON POST-SURGERY OUTCOMES IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA IN A RETROSPECTIVE COHORT
Za T. - EFFICACY OF ENOXAPARIN IN PREVENTING ADVERSE FETO-MATERNAL OUTCOMES IN CARRIERS OF ANTICOAGULANTS DEFICIENCY
  - THE G20210A PROTHROMBIN VARIANT (PT-G20210A) AND THE RISK OF THROMBOEMBOLISM AND FOETAL LOSS IN PREGNANT WOMEN
Zabolotskikh I.B. - THE PROTOCOL FOR DIAGNOSTICS AND INTENSIVE CARE OF DISSEMINATED INTRAVASCULAR COAGULATION SYNDROME
  - EVALUATION OF CLOT DENSITY AS AN INTEGRAL MARKER OF COAGULOPATHY
  - A TECHNIQUE FOR PREVENTION OF THROMBOSIS AFTER ABDOMINAL SURGERY
Zabotina A.M. - VARIATIONS OF PLATELET GLYCOPROTEIN IIB-IIIA QUANTITY AFFECTS PLATELET AGGREGATION AND SENSITIVITY TO GLYCOPROTEIN IIB-IIIA ANTAGONISTS
Zaccaria A. - PLASMA EXCHANGE AND ASPIRIN PLUS HIGH VERSUS STANDARD DOSE STEROIDS IN IDIOPATHIC THROMBOCYTOPENIC PURPURA (TTP): A PROSPECTIVE, RANDOMIZED STUDY BY THE ITALIAN GROUP FOR PTT
Zacharias C. - SECOND INTERIM ANALYSIS OF A LONG-TERM PHARMACOVIGILANCE PROJECT WITH A PLASMA DERIVED FVIII CONCENTRATE
  - LONG-TERM PHARMACOVIGILANCE UPDATE WITH A RECOMBINANT FVIII CONCENTRATE FOR THE TREATMENT OF HEMOPHILIA A
Zachoval R. - ANTIVIRAL TREATMENT OF HCV INFECTED YOUNG HAEMOPHILIACS AN UPDATE OF 14 YEARS EXPERIENCE IN A PRIVATE PRACTICE CCC
Zachrisson H. - REDUCED BLEEDING TIME PROLONGATION FOR THE REVERSIBLE P2Y12 ANTAGONIST AZD6140 COMPARED WITH THE THIENOPYRIDINE, CLOPIDOGREL, IN BOTH A RAT AND DOG MODEL OF COMBINED THROMBOSIS AND HEMOSTASIS
Zadra G. - SIMULTANEOUS GENOTYPING OF FXI TYPE II AND TYPE III MUTATIONS BY MULTIPLEX REAL-TIME PCR IN HEALTHY ITALIANS AND IN FXI-DEFICIENT PATIENTS
Zadro R. - INHERITED PROTHROMBOTIC RISK FACTORS IN CHILDREN WITH CEREBROVASCULAR DISORDERS
  - SENSITIVITY OF THE PLATELET FUNCTION ANALYZER (PFA-100) AS A SCREENING TEST FOR LABORATORY DIAGNOSIS OF VON WILLEBRAND DISEASE
  - ACL TOP PERFORMANCE IN ROUTINE COAGULATION TESTING
Zaguzin A. - THE CLINICAL RELEVANCE OF PLATELET HETEROGENEITY AND ACTIVATION IN PATIENT WITH ANTIPHOSPHOLIPID SYNDROME
Zakarija A. - ADAMTS13 ACTIVITY AND AUTOANTIBODIES IN IDIOPATHIC TTP: RESULTS FROM THE SERF-TTP GROUP
  - RISK FACTORS FOR THROMBOTIC THROMBOCYTOPENIC PURPURA: RESULTS OF THE SURVEILLANCE, EPIDEMIOLOGY AND RISK FACTORS FOR TTP (SERF-TTP) GROUP
  - THE USE OF ADVATE IN LIVER AND KIDNEY TRANSPLANTATION IN A PATIENT WITH HEMOPHILIA A, HEPATITIS C, AND HIV
Zalewski J. - REDUCED CLOT PERMEABILITY AND SUSCEPTIBILITY TO LYSIS IN PATIENTS WITH ACUTE CORONARY SYNDROME: EFFECTS OF INFLAMMATION AND OXIDATIVE STRESS
Zamolodchikova T. - DIRECT PROTECTIVE EFFECT OF ACTIVATED PROTEIN C ON MAST CELLS DEGRANULATION
Zamora-Rangel D. - A PROSPECTIVE STUDY OF PATIENTS WITH CANCER WITH A SHORT ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT) IN THE ABSENCE OF THROMBOSIS
Zampolli A. - TISSUE FACTOR DEPENDENT INITIATION OF PLATELET AND FIBRIN THROMBUS FORMATION
Zanardelli S. - FURTHER CHARACTERISATION OF ADAMTS13 INACTIVATION BY THROMBIN
  - THE CENTRAL ROLE OF THROMBIN IN HAEMOSTASIS
  - VWF A2 DOMAIN SEQUENCE 1533-1553: ITS ROLE IN CONTROLLING ADAMTS13 ACCESS TO THE Y1605-M1606 SCISSILE BOND
  - EVIDENCE FOR A HIGH AFFINITY ADAMTS13 BINDING SITE DISTAL TO THE VWF A DOMAINS
Zanchetta M. - THROMBOPHILIA IN PATIENTS WITH CRYPTOGENETIC STROKE AND PATENT FORAMEN OVALE
Zander N. - SPECIFIC AND SENSITIVE DETECTION OF THE INHIBITION OF THE PLATELET P2Y12-RECEPTOR WITH THE PFA-100 SYSTEM USING A NEW CARTRIDGE DESIGN
  - PRELIMINARY PERFORMANCE DATA OF A NEW QUANTITATIVE AND SENSITIVE D-DIMER ASSAY
Zandstra D.F. - COAGULATION PARAMETERS OF THE ISTH OVERT DIC SCORE: FIRST, THEIR DISTRIBUTION
Zanfa M. - EFFECTS OF 8-PRENYLNARINGENIN, A NOVEL PHYTOESTROGEN, ON HUMAN PLATELETS
  - MODULATION OF PLATELET FUNCTION BY THE ENDOCANNABINOID 2-ARACHIDONOYLGLYCEROL
  - DEHYDROEPIANDROSTERONE INHIBITS PLATELET AGGREGATION
Zannad F. - EFFECT OF TWO DOSES OF ORAL OESTROGEN REPLACEMENT THERAPY ON THE PROTEIN C SYSTEM IN POSTMENOPAUSAL WOMEN. A RANDOMISED DOUBLE BLIND PLACEBO-CONTROLLED STUDY
Zannin Z.M. - PLASMA INCOAGULABILITY INDUCED BY LONOMIA OBLIQUA BRISTLE EXTRACT IS ASSOCIATED WITH THE ABUNDANT PRESENCE OF LIPOCALINS
Zanolin S. - HYPERHOMOCYSTEINEMIA AND THROMBOSIS: THE DIAGNOSTIC ROLE OF POST METHIONINE-LOAD TEST
Zanon E. - FACTOR VIII (F8) GENE MUTATIONS AND IMMUNE TOLERANCE INDUCTION (ITI) IN HAEMOPHILIA A WITH INHIBITORS: DATA FROM THE ITALIAN ITI REGISTRY (THE PROFIT STUDY)
  - EFFECTIVE TREATMENT OF INTRACRANIAL HEMORRHAGE IN A SEVERE HEMOPHILIA B PATIENT
  - ENDOTHELIAL DYSFUNCTION IN HEMOPHILIA PATIENTS
  - EFFICACY AND SAFETY OF HIGHLY PURIFIED VWF/FVIII CONCENTRATES IN THE TREATMENT OF INHERITED VON WILLEBRAND DISEASE: RESULTS FROM THE RETROSPECTIVE ITALIAN STUDY ON 103 CASES
Zanotto D. - UPDATE OF THE ITALIAN HAEMOPHILIA B MUTATION DATABASE
  - PRENATAL DIAGNOSIS OF HAEMOPHILIA A BY USING INTRON 1 INVERSION MUTATION
Zapata-Gomez E. - EFFECT OF PROLAME, A 17 BETA-AMINOESTROGEN DERIVATIVE, ON CELL HEMOSTASIS
Zapfl C. - EVALUATION OF VWF CONCENTRATE ACTIVITY ASSAYS EMPLOYING COLLAGEN TYPES I AND III
Zapletal O. - IS IT POSSIBLE TO TREAT SAFELY AND EFFECTIVELY DEEP VEIN THROMBOSIS WITH CONTINUOUS I.V. INFUSION OF LMWH IN CHILDREN?
  - RFVIIA IS EFFECTIVE ALTERNATIVE TO APCC IN PROPHYLAXIS OF BLEEDING DURING IMMUNE TOLERANCE PROTOCOL IN HAEMOPHILIAC WITH INHIBITOR
Zappacosta B. - A PROPOSAL OF SCORING SYSTEM IN ASSESSMENT OF THROMBOTIC RISK IN CANCER PATIENT. A MONOCENTRIC STUDY
Zatsepin I.O. - HYPERHOMOCYSTEINEMIA AND VENOUS THROMBOSIS IN BELARUS
Zaturovska V. - TREATMENT OF DIC AS A COMPLICATION OF POLYTRANSFUSION AT PATIENT WITH OBSTETRIC HEMORRHAGE-CASE REPORT
Zaujec J. - ISG12 REGULATES ACTIVITY OF NUCLEAR RECEPTORS THEREBY MODULATING THE VASCULAR RESPONSE TO INJURY
Zavota L. - A SUCCESSFUL IMMUNOMODULATION-ITI RESCUE IN SEVERE HAEMOPHILIA A WITH HIGH RESPONDER INHIBITOR
Zavrelová J. - THE DIFFERENT SENSITIVITY OF TWO APTT REAGENTS FOR DIAGNOSIS OF LUPUS ANTICOANGULANT
Zcharia E. - HEPARANASE INDUCES TFPI EXPRESSION AND EXTRACELLULAR ACCUMULATION IN ENDOTHELIAL AND TUMOR CELLS
Zecca M. - CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA (CAMT): CLINICAL AND BIOLOGICAL CHARACTERIZATION OF FIVE NEW MUTATIONS
Zeerleder S. - VON WILLEBRAND FACTOR RELATED PARAMETERS IN SEVERE SEPSIS AND SEPTIC SHOCK
Zehnder J.L. - NASCOLA SURVEY OF HIT TESTING IN NORTH AMERICA
Zeilig G. - THROMBOPHILIA IS ASSOCIATED WITH HEPARIN THROMBOPROPHYLAXIS FAILURE IN PATIENTS WITH ACUTE TRAUMATIC SPINAL CORD INJURY
Zeinad A.K. - ACUTE THROMBOSIS IN A PATIENT WITH ACQUIRED FVIII INHIBITOR: CASE REPORT
  - DIFFICULTIES IN THE TREATMENT OF REFRACTORY IMMUNE THROMBOCYTOPENIC PURPURA WITH BLEEDING SYMPTOMS
  - MUNCHAUSEN SYNDROME X COAGULOPATHIES
Zelikovitz T. - PRO- AND ANTI-ANGIOGENIC CYTOKINES ARE CONDITIONALLY AND SELECTIVELY RELEASED FROM ALPHA-GRANULES UPON PLATELET STIMULATION
  - THE ROLE OF PLATELET MICROPARTICLES IN ANGIOGENESIS AND TUMOR BIOLOGY
Zemani F. - EX VIVO PRIMING OF EPC WITH SDF-1 BEFORE TRANSPLANTATION COULD INCREASE THEIR PROANGIOGENIC POTENTIAL
Zemanova M. - LOW MOLECULAR WEIGHT HEPARINS ARE EFFECTIVE AND SAFE IN THROMBOPROPHYLAXIS IN NEWLY DIAGNOSED MYELOMA PATIENTS DURING THE INDUCTION THERAPY
Zeng F.Y. - CONSTRUCTION AND IDENTIFICATION OF LENTIVIRUS - MEDIATED RNAI VECTORS CONTAINING HUMAN TISSUE FACTOR
Zeng W. - RESIDUAL VENOUS THROMBOSIS AFTER 5-7 MONTHS OF ORAL ANTICOAGULANT (OAC) THERAPY AS A PREDICTOR OF SUBSEQUENT RECURRENT VENOUS THROMBOEMBOLISM VTE
Zeng Q. - ACTIVATION OF HUMAN PLATELETS BY MISFOLDED PROTEINS
Zeng L. - TALIN HEAD-ROD INTERACTION MODULATES INTEGRIN BINDING TO THE TALIN HEAD DOMAIN
Zeni F. - EVOLUTION OF D-DIMERS LEVELS DURING HEPARIN THERAPY OF PATIENTS WITH CEREBRAL VENOUS THROMBOSIS
Zerbinati P. - RECOMBINANT HUMAN ACTIVATED PROTEIN C (RHAPC) IN PIG-TO-PRIMATE XENOTRANSPLANTATION
Zgouras D. - ETIOLOGY, CLINICAL COURSE AND TREATMENT OUTCOME OF PATIENTS WITH INFERIOR VENA CAVA THROMBOSIS
  - MALE GENDER INCREASES RISK OF VTE RECURRENCE AFTER SPONTANEOUS AND RISK-ASSOCIATED FIRST VENOUS THROMBOEMBOLISM
  - ARE PATIENTS WITH THROMBOPHILIA AND A HISTORY OF VENOUS THROMBOEMBOLISM AT HIGHER RISK TO ARTERIAL THROMBOTIC EVENTS?
Zhang W. - WHICH PATIENTS WITH VENOUS THROMBOSIS DO NOT REQUIRE SCREENING FOR MALIGNANCY? A PREDICTIVE MODEL TO IDENTIFY PATIENTS WITH VTE AT MINIMAL RISK OF MALIGNANCY
Zhang H. - EFFECTS OF JNJ-28045446 ON P2Y12 ADP RECEPTOR FUNCTION IN VITRO AND IN VIVO
  - INFLUENCE OF BUYANG HUANWU DECOCTION COMBINED UNSATURAT FATTY ACID IN RATS WITH HYPERLIPIDEMIAED
Zhang W. - HYPERFIBRINOLYTIC STATE IN ACUTE PROMYELOCYTIC LEUKEMIA ASSOCIATED WITH DISSEMINATED INTRAVASCULAR COAGULATION
Zhang M. - MICE TRANSGENIC FOR THROMBOMODULIN EXHIBIT PROTECTION FROM VENOUS THROMBOSIS
Zhang P. - THE COOPERATIVE ACTIVITY OF THE MIDDLE AND DISTAL CARBOXYL TERMINAL DOMAINS OF ADAMTS13 IS CRUCIAL FOR BINDING VON WILLEBRAND FACTOR UNDER FLOW
Zhang W. - GAMMA-GLUTAMYL CARBOXYLASE-DEPENDENT SECRETION OF PROTEIN Z
Zhang X.L. - IDENTIFICATION OF ANERGY-RELATED GENES IN IDIOPATHIC THROMBOCYTOPENIC PURPURA USING MICROARRAY ANALYSIS
Zhang A.J. - PHENOTYPE AND FUNCTION OF CD4+CD25+ REGULATORY T CELLS IN MOUSE MODEL OF EXPERIMENTAL TRANSIENT IMMUNE THROMBOCYTOPENIA AFTER TREATMENT WITH INDIRUBIN
Zhang B.J. - PHENOTYPE AND FUNCTION OF CD4+CD25+ REGULATORY T CELLS IN MOUSE MODEL OF EXPERIMENTAL TRANSIENT IMMUNE THROMBOCYTOPENIA AFTER TREATMENT WITH INDIRUBIN
Zhang C. - TETRASPANIN CD9 MODULATES VASCULAR SMOOTH MUSCLE CELL MIGRATION AND PROLIFERATION IN VITRO AND NEOINTIMA FORMATION IN VIVO
Zhang J. - HEME INDUCES TISSUE FACTOR EXPRESSION IN HUMAN LUNG MICROVASCULAR ENDOTHELIAL CELLS: RELATIONSHIP TO CLINICAL HEMOLYTIC STATES
Zhang H. - SIGNAL TRANSDUCTION PATHWAYS OF INTERLEUKIN-6 INDUCING TISSUE FACTOR EXPRESSION IN VASCULAR ENDOTHELIAL CELLS
Zhang L. - P2RY12 RECEPTOR POLYMORPHISMS (SNPS) IN PATIENTS WITH A HISTORY OF MYOCARDIAL INFARCTION
Zhang K. - IDENTIFICATION OF ETS1 AS ASE BINDING PROTEIN: UNIQUE ROLE IN AGE-RELATED GENE REGULATION
Zhao J. - RNAPC2, A NOVEL INHIBITOR OF TISSUE FACTOR/FACTOR VIIA COMPLEX, SYNERGIZES WITH 5-FU OR BEVACIZUMAB IN A MOUSE MODEL OF COLORECTAL CANCER
Zhao Y. - TWO NOVEL MONOCLONAL ANTIBODIES TO VWFA3 INHIBIT VWF-COLLAGEN AND VWFPLATELET GPIB INTERACTIONS
  - MECHANISM FOR THE INHIBITORY EFFECT OF TETRAMETHYLPYRAZINE ON THE EXPRESSION OF TISSUE FACTOR INDUCED BY TUMOR NECROSIS FACTOR IN ECV304 CELLS
Zhao H. - GENETIC MODIFICATION OF A SPECIES-DIVERGENT BOND IN VWF-A1 PEMITS HUMAN PLATELET THROMBUS FORMATION IN MICE
Zhao L. - HETEROCLITIN D, A COMPONENT OF PLANTS OF THE KADSURA SPECIES INHIBITS PAF-INDUCED PLATELET AGGREGATION, P-SELECTIN EXPRESSION AND PLATELET-LEUCOCYTE CONJUGATE FORMATION
Zhao Y. - VENOUS THROMBOEMBOLISM IN CHINA: A SINGLE-CENTER EXPERIENCE FOR 11 YEARS
  - PHENOTYPE AND FUNCTION OF CD4+CD25+ REGULATORY T CELLS IN MOUSE MODEL OF EXPERIMENTAL TRANSIENT IMMUNE THROMBOCYTOPENIA AFTER TREATMENT WITH INDIRUBIN
Zhao L. - EFFECTS ON PLATELET AND LEUCOCYTE FUNCTION BY INTRAVENOUS CHINESE MEDICINE WIDELY USED FOR PATIENTS WITH ISCHAEMIC DISEASE IN CHINA
Zhao J. - RNAPC2, A NOVEL INHIBITOR OF TISSUE FACTOR/FACTOR VIIA COMPLEX, SUPPRESSES LIVER AND LUNG METASTASES IN MOUSE MODELS OF COLORECTAL CANCER
Zhao Y. - PREVALENCE OF PROTEIN S (PS), PROTEIN C (PC), ANTITHROMBIN (AT) DEFICIENCY AND ACTIVATED PC RESISTANCE (APC-R) IN THE CHINESE POPULATION
Zheleva K. - INDUCTION OF ENDOTHELIAL CELL HYPERPERMEABILITY BY EXTRACELLULAR RNA
Zheng X. - OVEREXPRESSION OF ADAMTS13 BY LENTIVIRAL VECTOR ENCODING HUMAN ADAMTS13 GENE OFFERS SYSTEMIC PROTECTION AGAINST ARTERIAL THROMBOSIS IN A MOUSE MODEL
  - A CALCIUM-DEPENDENT PROTEASE CLEAVES VWF73 AT THE PEPTIDE BOND CORRESPONDING TO V1607-T1608 IN THE A2 DOMAIN
Zheng C. - HEREDITARY COAGULATION FACTOR XIII DEFICIENCY CAUSED BY A DELETION MUTATION OF F13A GENE
Zheng L. - CONSTRUCTION AND IDENTIFICATION OF LENTIVIRUS - MEDIATED RNAI VECTORS CONTAINING HUMAN TISSUE FACTOR
Zheng Q. - CONTRIBUTION OF INDIVIDUAL PURINOCEPTOR SUBTYPES TO PLATELET ACTIVATION BY VON WILLEBRAND FACTOR UNDER STATIC CONDITIONS
Zheng X. - THE COOPERATIVE ACTIVITY OF THE MIDDLE AND DISTAL CARBOXYL TERMINAL DOMAINS OF ADAMTS13 IS CRUCIAL FOR BINDING VON WILLEBRAND FACTOR UNDER FLOW
Zheng C.C. - ACQUIRED FACTOR VIII INHIBITORS IN NON-HEMOPHILIC PATIENTS: CLINICAL EXPERIENCE OF 16 CASES
Zheng C. - SERUM BAFF LEVELS IN PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA
Zheng Q. - CHARACTERIZATION OF A NEW METHOD TO ASSESS PLATELET ACTIVATION AND ERYTHROCYTE LYSIS DURING EXPOSURE TO PATHOPHYSIOLOGICAL SHEAR STRESS
Zherebcova S.V. - LYMPHOCYTE-PLATELET ADHESION IN PATIENTS WITH ANGINA PECTORIS
Zherebtsova S.V. - CHANGES IN PLATELET HAEMOSTASIS IN PATIENTS WITH ACUTE ACETIC ACID POISONING
Zhong D. - CHANGES OF TISSUE FACTOR PATHWAY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
Zhou X. - A SURVEY ON THE PREVALENCE OF VENOUS THROMBOEMBOLIC DISEASES IN GUANGZHOU OF CHINA
Zhou H. - LONG TERM OUTCOMES AMONG PATIENTS UNDER THE AGE OF 55 YEARS WHO ARE DIAGNOSED WITH FIRST-TIME IDIOPATHIC PULMONARY EMBOLISM (PE)
Zhou Z. - CD72 POLYMORPHISM ASSOCIATED WITH SUSCEPTIBILITY TO IDIOPATHIC THROMBOCYTOPENIA PURPURA IN CHINESE PATIENTS
Zhou J.J. - PLATELET ADHESION STUDIES ON NANOSTRUCTURED POLY (LACTIC-CO-GLYCOLIC ACID) CARBON NANOTUBE COMPOSITE
Zhou Z. - SERUM BAFF LEVELS IN PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA
Zhou S. - IN VIVO EFFECTS OF MURINE AND HUMAN APC
Zhou H. - COMPARISON OF THE 30-DAY INCIDENCE OF ISCHEMIC STROKE AND BLEEDING AFTER MAJOR SURGERY IN PATIENTS WITH AND WITHOUT ATRIAL FIBRILLATION (AF)
Zhou M.Y. - STUDY OF ANTI-ANGIOGENESIS EFFECT INDUCED BY MER IN VITRO AND ITS MECHANISM
Zhou W. - AN IAP RETROTRANSPOSON IN MOUSE ADAMTS13 GENE GENERATES ADAMTS13 VARIANTS LESS EFFECTIVE IN CLEAVING VWF MULTIMERS
Zhou H. - COMPARISON OF THE INCIDENCE OF RECURRENT VENOUS THROMBOEMBOLISM AFTER PREGNANCY-ASSOCIATED VTE VERSUS IDIOPATHIC VTE
  - HIGH RISK FOR VENOUS THROMBOEMBOLISM IN DIABETICS WITH HYPEROSMOLAR STATE: COMPARISON WITH OTHER ACUTE MEDICAL ILLNESSES
Zhou A. - FUNCTIONAL STRUCTURE OF THE SOMATOMEDIN B DOMAIN OF VITRONECTIN
Zhou S. - TRANSDUCTION OF COLONIC EPITHELIUM IN SEVERE HEMOPHILIA B BY NONINVASIVE APPROACH WITH RAAV2-HFIX RESULTED IN TRANSIENT EXPRESSION
Zhou Z. - INTERFERON GAMMA +874A/T AND INTERLEUKIN-4 INTRON3 VNTR GENE POLYMORPHISMS IN CHINESE PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA
Zhou Y. - INTERFERON GAMMA +874A/T AND INTERLEUKIN-4 INTRON3 VNTR GENE POLYMORPHISMS IN CHINESE PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA
Zhou H. - VENOUS THROMBOEMBOLISM IN ACUTE LEUKEMIA PATIENTS: INCIDENCE, RISK FACTORS, AND MORTALITY
  - CAUSE OF DEATH AMONG PATIENTS WITH LOCAL OR REGIONAL STAGE CANCER OF THE BREAST AND LUNG WHO DEVELOP VENOUS THROMBOEMBOLISM (VTE)
  - EFFECT OF SURGICAL PROCEDURES AND SPECIFIED RISK FACTORS ON THE INCIDENCE OF PERI-OPERATIVE STROKE IN PATIENTS WITH ATRIAL FIBRILLATION (AF)
Zhu T. - VENOUS THROMBOEMBOLISM IN CHINA: A SINGLE-CENTER EXPERIENCE FOR 11 YEARS
Zhu L. - LOSS OF SEMA4D SIGNALING BETWEEN PLATELETS DESTABILIZES ARTERIAL THROMBI AND REDUCES MYOCARDIAL INFARCT SIZE
Zhu J. - CD148 IS AN ESSENTIAL POSITIVE REGULATOR OF ITAM AND INTEGRIN RECEPTOR SIGNALLING IN PLATELETS
Zhu H. - GENOMIC AND STRUCTURAL ANALYSIS OF THE PROTECTIVE EFFECTS OF ACTIVATED PROTEIN C IN A BABOON MODEL OF E. COLI SEPSIS
  - PROTEINOMIC PROFILING OF TISSUE FACTOR MEDIATED PROTHROMBIN ACTIVATION PRODUCTS AND THEIR INHIBITION BY DIRECT ANTITHROMBIN AND ANTI-XA AGENTS
  - THE ROLE OF THE FACTOR V B DOMAIN IN FACTOR V-MMRN1 BINDING AND DISSOCIATION
Zhu W.H. - EFFECTS AND MECHANISMS OF BUYANG HUANWU DECOCTION ON THE CELL VIABILITY AND TF EXPRESSION INDUCED BY ANG? IN ENDOTHELIAL CELLS
Zhu Y.Y. - THE SCREENING ASSAY OF PLATELET- ASSOCIATED IMMUNOGLOBULIN G CAN NOT IMPROVE THE SENSITIVITY OF MONOCLONAL ANTIBODY IMMOBILIZATION OF PLATELET ANTIGENS ASSAY IN IMMUNE THROMBOCYTOPENIC PURPURA
Zhu T. - PREVALENCE OF PROTEIN S (PS), PROTEIN C (PC), ANTITHROMBIN (AT) DEFICIENCY AND ACTIVATED PC RESISTANCE (APC-R) IN THE CHINESE POPULATION
Zhu H. - EFFECT OF ANTIDEPRESSANT DRUG TREATMENT ON INFLAMMATORY AND PLATELET ACTIVATION BIOMARKERS IN DEPRESSION
Zhu J. - CD148 IS A POSITIVE REGULATOR OF PLCGAMMA2 ACTIVATION BY GPVI
Zhukov O. - IDENTIFICATION OF VON WILLEBRAND DISEASE TYPE 2N BY VWF-FVIII BINDING ACTIVITY ASSAY IN PATIENTS AND HETEROZYGOUS CARRIERS
Zhuo J. - INDUCTION OF FIX TOLERANCE BY DIRECT INTRAMUSCULAR INJECTION OF AAV IS AAV-DOSE/FIX-LEVEL DEPENDENT
  - EFFICIENT INDUCTION OF IMMUNE TOLERANCE TO FIX FOLLOWING DIRECT INTRAMUSCULAR GENE TRANSFER
  - TOLERANCE INDUCTION TO FIX IN MICE WITH PRE-EXISTING ANTI-FIX IMMUNITY FOLLOWING DIRECT INTRAMUSCULAR INJECTION OF AAV
Zieger B. - COMBINED FACTOR V AND FACTOR VIII DEFICIENCY: MUTATION ANALYSIS AND ETHNICAL BACKGROUND OF FIVE PATIENTS
Zielinski L. - C-REACTIVE PROTEIN, LIPOPROTEIN(A) AND HOMOCYSTEINE AS CONTRIBUTORS TO FIBRIN CLOT PERMEABILITY AND LYSABILITY IN SUBJECTS SCHEDULED FOR CORONARY ARTERY BYPASS GRAFTING
  - FOLIC ACID ADMINISTRATION AND PLATELET ACTIVATION AT THE SITE OF MICROVASCULAR INJURY IN SUBJECTS WITH ELEVATED TOTAL HOMOCYSTEINE
Zielinski C. - A HIGH PLATELET COUNT INDEPENDENTLY PREDICTS VENOUS THROMBOEMBOLISM IN CANCER PATIENTS
Zimarino M. - INHIBITORY EFFECT OF COFFEE ON PLATELET AGGREGATION
  - SURGICAL BLEEDING AFTER PREOPERATIVE UNFRACTIONATED HEPARIN AND LOW MOLECULAR WEIGHT HEPARIN AT CORONARY BYPASS SURGERY
Zimmer A. - TACHYKININS AND THE NEUROKININ RECEPTOR 1 ARE REQUIRED FOR PLATELET THROMBUS FORMATION
Zimmermann R. - SECOND INTERIM ANALYSIS OF A LONG-TERM PHARMACOVIGILANCE PROJECT WITH A PLASMA DERIVED FVIII CONCENTRATE
  - SEVEN NOVEL MISSENSE MUTATIONS IN THE VITAMIN K EPOXIDE REDUCTASE COMPLEX SUBUNIT 1 (VKORC1) CAUSE HEREDITARY COUMARIN RESISTANCE
Zimmermann A. - THROMBOPHILIA AND SPONTANEOUS ABORTION THERAPY WITH LMW-HEPARI
Zimmermann R. - SUCCESSFUL INHIBITOR-ELIMINATION W ITH RITUXIMAB IN ONE PATIENT WITH A CARRIER STATE FOR HEMOPHILIA A AND 4 PATIENTS WITH ACQUIRED HEMOPHILIA A
Zimnoch L. - EXPRESSION OF TISSUE FACTOR (TF), FACTOR X, PROTHROMBIN FRAGMENT 1+2 (F 1+2) AND FIBRIN IN BREAST CANCER: COMPARISON BETWEEN PRIMARY TUMOR AND METASTATIC LESIONS IN REGIONAL LYMPH NODES
Zinderman C. - INHIBITOR DEVELOPMENT IN SEVERE HEMOPHILIA A: IS THE RISK ASSOCIATED WITH PRODUCT TYPE?
Zito F. - ASSOCIATION OF C-REACTIVE PROTEIN AND WHITE BLOOD CELL COUNT WITH PHYSICAL ACTIVITY IN HEALTHY SUBJECTS
  - ASSOCIATION OF C-REACTIVE PROTEIN AND ALCOHOL INTAKE IN HEALTHY MEN AND WOMEN FROM THE MOLI-SANI POPULATION
  - ASSOCIATION OF C-REACTIVE PROTEIN, OBESITY AND METABOLIC SYNDROME IN HEALTHY MEN AND WOMEN FROM THE MOLI-SANI POPULATION
  - FIBRIN D-DIMERS IS ASSOCIATED WITH PREVALENT CARDIOVASCULAR EVENTS IN THE MOLI-SANI STUDY
Zitouni M. - THROMBOPHILIA MARKERS IN SYSTEMIC LUPUS ERYTHEMATOSUS A CASE CONTROL STUDY
Zitzmann N. - IDENTIFICATION OF NOVEL TYROSINE PHOSPHORYLATED SIGNALLING PROTEINS FOLLOWING IIb3-MEDIATED PLATELET SPREADING: INVOLVEMENT OF THE IMMUNOGLOBULIN SUPERFAMILY MEMBERS G6B-B AND G6F, AND THE NOVEL PLATELET ADAPTER DOK-3
Zivelin A. - The contribution of phospholipids (PL) to thrombin generation (TG) induced by factor eight inhibitor bypassing activity (FEIBA) and recombinant factor VIIa (rFVIIa)
  - TWO APPARENT MISSENSE MUTATIONS IN EXONS OF THE FACTOR XI GENE CAUSE SPLICING DEFECTS DISPLAYING A NOVEL MECHANISM FOR MUTATIONS IN CLOTTING FACTORS
  - ALPHA V SUPPRESSION BY SIRNA AUGMENTS OR INHIBITS VEGF AND VEGFR-2 EXPRESSION DEPENDING ON THE ORIGIN OF ENDOTHELIAL CELLS
  - FACTOR XI PHENOTYPE-GENOTYPE CORRELATIONS
  - A RECOMBINANT FACTOR VIIA ANALOGUE WITH ENHANCED POTENCY, EXPRESSED BY THROMBIN GENERATION, AND PHOSPHOLIPIDS DEPENDENCY: AN IN VITRO STUDY
  - FACTOR XI (FXI) IS PRESENT IN ANTI-D PREPARATIONS AND CAN INDUCE AN INHIBITOR TO FXI IN PATIENTS WITH SEVERE FXI DEFICIENCY
  - THREE RESIDUES (L284, I290, Y329) IN THE APPLE 4 DOMAIN OF FACTOR XI (FXI) ARE ESSENTIAL FOR COVALENT DIMERIZATION OF FXI SUBUNITS
  - THROMBOPHILIA IS ASSOCIATED WITH HEPARIN THROMBOPROPHYLAXIS FAILURE IN PATIENTS WITH ACUTE TRAUMATIC SPINAL CORD INJURY
  - CAN THROMBIN GENERATION (TG) BE USED TO MONITOR RFVIIA TREATMENT: IN VIVO "MINI-PK" STUDY IN HEMOPHILIA A PATIENTS
Zmudka K. - THROMBIN GENERATION PROFILES IN PATIENTS WITH ACUTE CORONARY SYNDROME AND STABLE CORONARY ARTERY DISEASE: A COMPUTATIONAL ANALYSIS
  - NO DECREASE IN THROMBIN FORMATION AT THE SITE OF MICROVASCULAR INJURY IN PATIENTS TREATED WITH CLOPIDOGREL
  - REDUCED CLOT PERMEABILITY AND SUSCEPTIBILITY TO LYSIS IN PATIENTS WITH ACUTE CORONARY SYNDROME: EFFECTS OF INFLAMMATION AND OXIDATIVE STRESS
Zobairi F. - ELEVATED LEVELS OF CIRCULATING PROCOAGULANT MICROPARTICLES IN PATIENTS WITH BETA-THALASSEMIA INTERMEDIA
Zogg M. - MATERNAL PLATELETS AND THE THROMBIN RECEPTOR, PAR4, DISRUPT PLACENTAL MORPHOGENESIS AND CAUSE FETAL LOSS IN FACTOR V LEIDEN MICE
Zoja C. - ROSUVASTATIN EXERTS RENOPROTECTIVE EFFECTS IN STROKE-PRONE RATS BY MODULATING THE PLASMINOGEN/PLASMIN SYSTEM AND THE METALLOPROTEASES EXPRESSION
Zolcinski M. - THROMBIN GENERATION IN CHRONICALLY ANTICOAGULATED PATIENTS
Zolfaghari S. - HEREDITARY THROMBOPHILIC DEFECTS IN IRANIAN PATIENTS WITH CEREBRO VASCULAR ACCIDENT
  - HEREDITARY DEFICIENCIES OF ANTITHROMBIN, PROTEIN S, AND THE PROTEIN C PATHWAY IN IRANIAN DVT PATIENTS
Zolghadri Z. - INFLUENCE OF INHERITED THROMBOPHILIA WITH RECURRENT PREGNANCY LOSS
Zoltick P.W. - OVEREXPRESSION OF ADAMTS13 BY LENTIVIRAL VECTOR ENCODING HUMAN ADAMTS13 GENE OFFERS SYSTEMIC PROTECTION AGAINST ARTERIAL THROMBOSIS IN A MOUSE MODEL
Zondag M. - CLINICAL FACTORS INFLUENCING THE SENSITIVITY TO WARFARIN WHEN RESTARTED AFTER SURGERY
Zopf D. - DEVELOPMENT OF LONG-ACTING FVIIA DERIVATIVES BY GLYCOPEGYLATION
  - EFFECT OF GLYCOPEGYLATION ON THE PHARMACOKINETIC PROPERTIES OF FVIIA
Zorenko V.Y. - AIRWAY OBSTRUCTION CAUSED BY HEMORRHAGE IN PATIENTS (PTS) WITH INHIBITOR HEMOPHILIA
Zotta L. - INADEQUATE CARDIOVASCULAR PREVENTION AND DIAGNOSTIC VASCULAR GUIDELINES ADHERENCE IN OUTPATIENTS: AN OBSERVATIONAL STUDY IN A COHORT OF NORTHERN ITALY
Zotz R.B. - THE Y2561 ALLELE OF A COMMON POLYMORPHISM IN THE C1 DOMAIN OF VON WILLEBRAND FACTOR APPEARS AS A NOVEL RISK FACTOR FOR MYOCARDIAL INFARCTION
  - SUCCESSFUL USE OF RECOMBINANT FACTOR VIIA (RFVIIA, NOVOSEVEN) IN TWO PATIENTS WITH BERNARD SOULIER SYNDROME AND DENTAL EXTRACTION
  - LONGTERM PROPHYLACTIC TREATMENT WITH FACTOR IX P IN A PATIENT WITH SEVERE CONGENITAL FACTOR X DEFICIENCY
  - RISK OF RECURRENT VENOUS THROMBOEMBOLISM IN A SUBSEQUENT PREGNANCY IN WOMEN WITH A FIRST HISTORY OF VENOUS THROMBOSIS
  - LONGTERM PROPHYLACTIC TREATMENT WITH RECOMBINANT FACTOR VIIA (NOVOSEVEN) IN SEVERE CONGENITAL FACTOR VII DEFICIENT PATIENTS
  - EVALUATION OF VENOUS THROMBOEMBOLIC RISK PROFILES IN ACUTELY ILL MEDICAL PATIENTS IN HOSPITAL AND OUTPATIENT SETTINGS: THE STATUS REGISTRY
  - INTERACTION BETWEEN ORAL CONTRACEPTIVE USE AND COAGULATION FACTOR LEVELS IN DEEP VEIN THROMBOSIS
  - RISK DETERMINANTS OF ARTERIAL THROMBOSIS INCREASE THE RISK OF INTRAUTERINE GROWTH RESTRICTION (IGR)
  - RISK DETERMINANTS OF NONARTERITIC ISCHEMIC OPTIC NEUROPATHY (NAION)
  - HAEMATE HS IN PATIENTS WITH SEVERE BLEEDING UNDERGOING VALVE REPLACEMENT DUE TO AORTIC STENOSIS (HAVAS-STUDY)
  - RISK STRATIFICATION OF RECURRENT VENOUS THROMBOEMBOLISM
  - FONDAPARINUX IS A SAFE AND EFFECTIVE ALTERNATIVE ANTICOAGULANT IN PREGNANT WOMEN WITH INTOLERANCE TO LOW-MOLECULAR- WEIGHT HEPARINS AND HEPARINOIDS
  - CLINICAL EXPERIENCE WITH FACTOR VIII/VON-WILLEBRAND-FACTOR CONCENTRATE HAEMATE P RESULTS ON EFFICACY AND SAFETY IN A SINGLE CENTRE REGISTRY
  - INCREASED PLASMINOGEN ACTIVITY IS AN INDEPENDENT PREDICTOR OF BLEEDING IN HEMOPHILIACS
Zou J. - IN VIVO EFFECTS OF MURINE AND HUMAN APC
Zouain D. - ABNORMAL PATTERN FOR FVIII GENE INTRON 1 INVERSION IN ONE BRAZILIAN FAMILY
Zoumbos N. - FV LEIDEN, FII G20210A AND MTHFR T677T GENOTYPES: IS THEIR EVALUATION A USEFUL TOOL IN THE ETIOLOGICAL APPROACH OF THE EARLY RECURRENT PREGNANCY LOSSES IN THE GREEK POPULATION?
Zozulya N.I. - FIRST EXPERIENCE WITH IMMUNE TOLERANCE INDUCTION IN HAEMOPHILIA A PATIENTS WITH INHIBITOR TO FACTOR VIII IN RUSSIA
  - HOME TREATMENT WITH RECOMBINANT VIIA FACTOR IN HEMOPHILIA PATIENTS WITH INHIBITOR
Zuazu I. - CLINICAL, GENETIC, FUNCTIONAL AND CONFORMATIONAL HETEROGENEITY OF CONGENITAL ANTITHROMBIN DEFICIENCY. RESULTS FROM 27 UNRELATED CASES
Zubarovskaya L.S. - D-DIMER IN PATIENTS WITH ACUTE LEUKEMIA AFTER TRANSPLANTATION OF HEMATOPOIETIC STEM CELLS
Zubovsky D.K. - CORRECTION HAEMOSTASIOLOGIC AND RHEOLOGIC DISTURBANCES AT THE PATIENTS WITH ISCHEMIC HEART AND BRAIN DESIASES BY MEANS OF COMBINATION OF PHARMACOLOGICAL DRUGS AND EXTRACORPOREAL AUTOBLOOD-MAGNET-THERAPY
Zucker M. - FACTOR XI PHENOTYPE-GENOTYPE CORRELATIONS
  - TWO APPARENT MISSENSE MUTATIONS IN EXONS OF THE FACTOR XI GENE CAUSE SPLICING DEFECTS DISPLAYING A NOVEL MECHANISM FOR MUTATIONS IN CLOTTING FACTORS
  - THREE RESIDUES (L284, I290, Y329) IN THE APPLE 4 DOMAIN OF FACTOR XI (FXI) ARE ESSENTIAL FOR COVALENT DIMERIZATION OF FXI SUBUNITS
  - FACTOR XI (FXI) IS PRESENT IN ANTI-D PREPARATIONS AND CAN INDUCE AN INHIBITOR TO FXI IN PATIENTS WITH SEVERE FXI DEFICIENCY
Zuehlsdorf M. - THE EFFECT OF AGE AND GENDER ON THE PHARMACOLOGY AND SAFETY OF THE ORAL, DIRECT FACTOR XA INHIBITOR RIVAROXABAN
  - EFFECT OF HEPATIC IMPAIRMENT ON THE PHARMACOKINETICS, PHARMACODYNAMICS AND TOLERABILITY OF RIVAROXABAN AN ORAL, DIRECT FACTOR XA INHIBITOR
  - RIVAROXABAN AN ORAL, DIRECT FACTOR XA INHIBITOR HAS NO CLINICALLY RELEVANT INTERACTION WITH ACETYLSALICYLIC ACID OR NAPROXEN
Zueva Y.E. - SPECIFIC PHENOTYPE OF PLATELETS GPIB, GPIIB, GPIIIA AND GMP-140 IN PATIENTS WITH LOW LIMB VARICOSE VEIN DISEASE
Zufferey P.J. - DOES TRANEXAMIC ACID DECREASE ERYTHROCYTE TRANSFUSION IN PATIENTS UNDERGOING HIP FRACTURE SURGERY WITH FONDAPARINUX FOR PREVENTION OF VENOUS THROMBOEMBOLISM ?
Zuniga P. - TRANEXAMIC ACID DELAYS THE CLOT LYSIS TIME, AND INCREASES THE ENDOGENOUS THROMBIN GENERATION AND PLASMA PROCARBOXYPEPTIDASE U (TAFI) LEVELS IN PATIENTS WITH MUCOCUTANEOUS BLEEDING
Zurlo F. - WHOLE BLOOD PROCOAGULANT ACTIVITY: A POSSIBILE CELLULAR MARKER OF CARDIOVASCULAR RISK?
Zurro M. - INHIBITORY EFFECT OF COFFEE ON PLATELET AGGREGATION
  - HIGH GLUCOSE INHIBITS NITRIC OXIDE PRODUCTION THROUGH AN HYPEROSMOLAR EFFECT, WITHOUT INDUCING ENDOTHELIAL CELL ADHESION SURFACE EXPRESSION IN HUMAN ENDOTHELIAL CELLS
Zwaginga J.J. - IN VIVO STUDIES OF NEWLY IDENTIFIED PLATELET-SPECIFIC GENES BY HUMAN PLATELET FORMATION IN NOD/SCID MICE AFTER TRANSPLANTATION OF CD34-POSITIVE CELLS
Zwang E. - HEPARANASE MODULATES HEPARINOIDS ANTICOAGULANT ACTIVITIES VIA NON-ENZYMATIC MECHANISMS
Zwicker J.I. - CANCER-ASSOCIATED THROMBOSIS: TISSUE FACTOR-BEARING MICROPARTICLES ARE ASSOCIATED WITH AN INCREASED RISK OF VENOUS THROMBOEMBOLIC EVENTS IN CANCER PATIENTS
Zwinderman A.H. - PLATELET RECEPTOR P2Y12 HAPLOTYPES PREDICT RESTENOSIS AFTER PERCUTANEOUS CORONARY INTERVENTIONS
Zwingel C. - HETEROGENEITY OF HPA-3 ALLOANTIBODIES: CONSEQUENCES FOR THE DIAGNOSIS OF FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA
Zytaruk N. - DALTEPARIN THROMBOPROPHYLAXIS IN CRITICALLY ILL PATIENTS WITH SEVERE RENAL INSUFFICIENCY: THE DIRECT STUDY
| ISTH 2009